Kurs & Likviditet
Kalender
2025-02-21 | Bokslutskommuniké 2024 |
2024-11-15 | Kvartalsrapport 2024-Q3 |
2024-10-21 | Extra Bolagsstämma 2024 |
2024-08-23 | Kvartalsrapport 2024-Q2 |
2024-06-28 | Årsstämma 2024 |
2024-05-29 | Kvartalsrapport 2024-Q1 |
2024-05-17 | X-dag ordinarie utdelning CLS B 0.00 SEK |
2024-04-25 | Split CLS B 200:1 |
2024-02-23 | Bokslutskommuniké 2023 |
2023-11-17 | Kvartalsrapport 2023-Q3 |
2023-08-25 | Kvartalsrapport 2023-Q2 |
2023-06-29 | Årsstämma 2023 |
2023-06-22 | X-dag ordinarie utdelning CLS B 0.00 SEK |
2023-06-08 | Extra Bolagsstämma 2023 |
2023-05-25 | Kvartalsrapport 2023-Q1 |
2023-02-23 | Bokslutskommuniké 2022 |
2022-11-22 | Extra Bolagsstämma 2022 |
2022-11-17 | Kvartalsrapport 2022-Q3 |
2022-08-25 | Kvartalsrapport 2022-Q2 |
2022-06-29 | X-dag ordinarie utdelning CLS B 0.00 SEK |
2022-06-28 | Årsstämma 2022 |
2022-05-19 | Kvartalsrapport 2022-Q1 |
2022-02-24 | Bokslutskommuniké 2021 |
2021-11-18 | Kvartalsrapport 2021-Q3 |
2021-08-24 | Kvartalsrapport 2021-Q2 |
2021-06-29 | X-dag ordinarie utdelning CLS B 0.00 SEK |
2021-06-28 | Årsstämma 2021 |
2021-05-19 | Kvartalsrapport 2021-Q1 |
2021-03-31 | Extra Bolagsstämma 2021 |
2021-02-26 | Bokslutskommuniké 2020 |
2020-11-19 | Kvartalsrapport 2020-Q3 |
2020-08-26 | Kvartalsrapport 2020-Q2 |
2020-06-12 | X-dag ordinarie utdelning CLS B 0.00 SEK |
2020-06-11 | Årsstämma 2020 |
2020-05-28 | Kvartalsrapport 2020-Q1 |
2020-02-28 | Bokslutskommuniké 2019 |
2019-11-21 | Kvartalsrapport 2019-Q3 |
2019-08-22 | Kvartalsrapport 2019-Q2 |
2019-06-12 | X-dag ordinarie utdelning CLS B 0.00 SEK |
2019-05-17 | Årsstämma 2019 |
2019-05-16 | Kvartalsrapport 2019-Q1 |
2019-03-18 | Extra Bolagsstämma 2019 |
2019-02-14 | Bokslutskommuniké 2018 |
2018-11-22 | Kvartalsrapport 2018-Q3 |
2018-08-23 | Kvartalsrapport 2018-Q2 |
2018-06-20 | Årsstämma 2018 |
2018-06-14 | X-dag ordinarie utdelning CLS B 0.00 SEK |
2018-05-24 | Kvartalsrapport 2018-Q1 |
2018-05-18 | Extra Bolagsstämma 2018 |
2018-02-22 | Bokslutskommuniké 2017 |
2017-11-16 | Kvartalsrapport 2017-Q3 |
2017-07-17 | Kvartalsrapport 2017-Q2 |
2017-06-28 | X-dag ordinarie utdelning CLS B 0.00 SEK |
2017-06-27 | Årsstämma 2017 |
2017-05-18 | Kvartalsrapport 2017-Q1 |
2017-01-31 | Bokslutskommuniké 2016 |
2017-01-20 | Extra Bolagsstämma 2017 |
2016-11-17 | Kvartalsrapport 2016-Q3 |
2016-08-18 | Kvartalsrapport 2016-Q2 |
2016-06-16 | Årsstämma 2016 |
2016-05-19 | Kvartalsrapport 2016-Q1 |
2016-02-21 | Bokslutskommuniké 2015 |
2015-11-19 | Kvartalsrapport 2015-Q3 |
2015-08-20 | Kvartalsrapport 2015-Q2 |
2015-06-12 | X-dag ordinarie utdelning CLS B 0.00 SEK |
2015-06-11 | Årsstämma 2015 |
2015-05-21 | Kvartalsrapport 2015-Q1 |
2015-02-23 | Bokslutskommuniké 2014 |
2014-11-14 | Kvartalsrapport 2014-Q3 |
2014-08-20 | Kvartalsrapport 2014-Q2 |
2014-06-18 | X-dag ordinarie utdelning CLS B 0.00 SEK |
2014-06-17 | Årsstämma 2014 |
2014-05-22 | Kvartalsrapport 2014-Q1 |
2014-02-24 | Bokslutskommuniké 2013 |
2013-11-22 | Kvartalsrapport 2013-Q3 |
2013-09-19 | Extra Bolagsstämma 2013 |
2013-08-20 | Kvartalsrapport 2013-Q2 |
2013-06-10 | X-dag ordinarie utdelning CLS B 0.00 SEK |
2013-06-07 | Årsstämma 2013 |
2013-05-24 | Kvartalsrapport 2013-Q1 |
2013-02-25 | Bokslutskommuniké 2012 |
2012-11-23 | Kvartalsrapport 2012-Q3 |
2012-08-24 | Kvartalsrapport 2012-Q2 |
2012-06-08 | X-dag ordinarie utdelning CLS B 0.00 SEK |
2012-06-07 | Årsstämma 2012 |
2012-04-20 | Kvartalsrapport 2012-Q1 |
2012-01-09 | Bokslutskommuniké 2011 |
2012-01-04 | Extra Bolagsstämma 2012 |
2011-11-21 | Kvartalsrapport 2011-Q3 |
2011-09-26 | Kapitalmarknadsdag 2010 |
2011-08-22 | Kvartalsrapport 2011-Q2 |
2011-06-10 | Årsstämma 2011 |
2011-05-20 | Kvartalsrapport 2011-Q1 |
2011-02-24 | Bokslutskommuniké 2010 |
2010-11-24 | Kvartalsrapport 2010-Q3 |
2010-08-25 | Kvartalsrapport 2010-Q2 |
2010-05-28 | X-dag ordinarie utdelning CLS B 0.00 SEK |
2010-05-26 | Kvartalsrapport 2010-Q1 |
2010-02-26 | Bokslutskommuniké 2009 |
2009-11-30 | Kvartalsrapport 2009-Q3 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
Company Goal to Enable Minimally-Invasive, Focal Therapy Procedure to be Performed in an Office Setting or Clinic under Local Anesthetic
INDIAN WELLS, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation (FLA) systems, today announced the new generation of its TRANBERG® Thermal Therapy System is being exhibited at the Western Section AUA - 97th Annual Meeting at Indian Wells, CA this October 31 to Nov 4, 2021. The new TRANBERG thermal therapy system is undergoing clinical studies and being tested using MRI-US, fusion-guided laser ablation for the minimally-invasive, targeted focal therapy of prostate tumors. CLS’s goal is to enable high precision, focal laser ablation of prostate cancer tumors to be performed under local anesthetic in an office setting or clinic as well as hospitals. Visit the company at booth # TT24.
“We’re excited to show our new TRANBERG thermal therapy system to this prestigious group of urologist physician attendees,” stated Michael Magnani, Managing Director of CLS Americas. “CLS is pleased by the growing acceptance in minimally invasive, MRI-US fusion-guided biopsies and cryoablation of prostate cancer tumors. We believe our focal laser ablation system will perform well and produce excellent results using the same fusion-guidance technology.”
High Precision Thermal Therapy System
The TRANBERG® |Thermal Therapy System has been developed for image-guided, high-precision soft tissue thermal therapy and ablation procedures. For the US market, the system is configured for CT or MRI-US, fusion image-guided procedures, and can be configured for tissue temperature feedback for precise temperature and ablation control. It includes a desk-top mobile laser unit, innovative non-cooled laser applicators, external tissue temperature probe sensors, and procedure specific accessories. Its non-cooled, laser fiber technology optimizes heat distribution, eliminates the need for external cooling, and helps reduce procedure times.
About Clinical Laserthermia Systems
Clinical Laserthermia Systems AB (publ) develops and commercializes its TRANBERG® Thermal Therapy System, including sterile disposables and accessories, for image-guided, minimally invasive focal laser ablation of soft tissue. CLS is headquartered in Lund and has subsidiaries in Germany, the US and Singapore. CLS is listed on the Nasdaq First North Growth Market under the symbol CLS B. The Certified Advisor (CA) is FNCA Sweden AB, Tel: +46 8 528 00 399. E-mail: info@fnca.se. US Tel: 1 (949) 504-5440. For more information about CLS, visit the Company's website: www.clinicallaser.se.